These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16436754

  • 1. Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae.
    Leuthner KD, Cheung CM, Rybak MJ.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):813-6. PubMed ID: 16436754
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.
    Sun HK, Lee SY, Banevicius MA, Du X, Maglio D, Nicolau DP.
    J Antimicrob Chemother; 2005 Sep; 56(3):559-65. PubMed ID: 16024590
    [Abstract] [Full Text] [Related]

  • 3. Pulsatile delivery of amoxicillin against Streptococcus pneumoniae.
    Cha R, Rybak MJ.
    J Antimicrob Chemother; 2004 Dec; 54(6):1067-71. PubMed ID: 15486084
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.
    Odenholt I, Cars O, Löwdin E.
    J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517
    [Abstract] [Full Text] [Related]

  • 5. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation.
    Sevillano D, Calvo A, Giménez MJ, Alou L, Aguilar L, Valero E, Carcas A, Prieto J.
    J Antimicrob Chemother; 2004 Dec; 54(6):1148-51. PubMed ID: 15489246
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae.
    Pérez-Trallero E, Marimón JM, Ercibengoa M, Giménez MJ, Coronel P, Aguilar L.
    Clin Microbiol Infect; 2007 Sep; 13(9):937-40. PubMed ID: 17617182
    [Abstract] [Full Text] [Related]

  • 7. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
    Anderson R, Steel HC, Cockeran R, Smith AM, von Gottberg A, de Gouveia L, Brink A, Klugman KP, Mitchell TJ, Feldman C.
    J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R, Steel HC, Cockeran R, von Gottberg A, de Gouveia L, Klugman KP, Mitchell TJ, Feldman C.
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.
    J Antimicrob Chemother; 2008 Nov; 62(5):1156-8. PubMed ID: 18667449
    [No Abstract] [Full Text] [Related]

  • 10. Both penicillin and amoxycillin should be tested in antimicrobial surveillance for Streptococcus pneumoniae.
    Garau J.
    Clin Microbiol Infect; 2005 May; 11(5):422-3. PubMed ID: 15819875
    [No Abstract] [Full Text] [Related]

  • 11. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin.
    Amores R, Alou L, Giménez MJ, Sevillano D, Gómez-Lus ML, Aguilar L, Prieto J.
    Int J Antimicrob Agents; 2004 Jul; 24(1):79-82. PubMed ID: 15225866
    [Abstract] [Full Text] [Related]

  • 12. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori primary resistant strains over 11 years in French children.
    Kalach N, Serhal L, Asmar E, Campeotto F, Bergeret M, Dehecq E, Spyckerelle C, Charkaluk ML, Decoster A, Dupont C, Raymond J.
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):217-22. PubMed ID: 17662555
    [Abstract] [Full Text] [Related]

  • 14. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
    Díaz-Reganon J, Alarcón T, Domingo D, López-Brea M.
    Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
    [Abstract] [Full Text] [Related]

  • 15. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
    Sevillano D, Aguilar L, Alou L, Giménez MJ, González N, Echeverría O, Torrico M, Valdes L, Coronel P, Prieto J.
    Chemotherapy; 2008 Mar; 54(2):84-90. PubMed ID: 18303256
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 17. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
    Schentag JJ, Klugman KP, Yu VL, Adelman MH, Wilton GJ, Chiou CC, Patel M, Lavin B, Paladino JA.
    Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
    [Abstract] [Full Text] [Related]

  • 18. Classification of Streptococcus pneumoniae based on in-vitro susceptibility to oxyiminocephalosporins.
    Kitayama R, Minami S, Mitsuyama J, Yamada H, Watanabe Y.
    J Antimicrob Chemother; 1999 Jan; 43(1):162-4. PubMed ID: 10381121
    [No Abstract] [Full Text] [Related]

  • 19. [Sequential therapy regimen for Helicobacter pylori infection in children].
    Kalach N, Serhal L, Bergeret M, Spyckerelle C, Dupont C, Raymond J.
    Arch Pediatr; 2008 Feb; 15(2):200-1. PubMed ID: 18249101
    [No Abstract] [Full Text] [Related]

  • 20. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY, Lee SW, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Lee HS, Choi JH, Kim CD, Ryu HS.
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.